Marion Malphettes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marion Malphettes has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Agathe Masseau
Médecine Interne, CHU de Nantes
1 shared publicationAntoinette Perlat
Médecine Interne, CHU Hôpital Sud, Rennes
1 shared publication- Bernard Bonnotte
Department of Internal Medicine and Clinical Immunology, Referral Center for Rare Systemic Autoimmune and Autoinflammatory Diseases, Dijon-Bourgogne University Hospital, University EPE Bourgogne Europe, Dijon, France
1 shared publication Bouchra Asli
Département d'immunologie, Assistance Publique Hôpitaux de Paris (AP-HP) INSERM U1126, Centre Hayem, Hôpital Saint-Louis
1 shared publicationClaire Fieschi
Département d'immunologie, Assistance Publique Hôpitaux de Paris (AP-HP) INSERM U1126, Centre Hayem, Hôpital Saint-Louis
1 shared publicationDEFicit Immunitaire de l'adulte Study Group
1 shared publication
Latest Publications
- Open Access
- 31 March 2015
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 61 (2) , e13-e19
Good Syndrome: An Adult-Onset Immunodeficiency Remarkable for Its High Incidence of Invasive Infections and Autoimmune Complications
Background. Good syndrome (GS) is a rare condition in which thymoma is associated with hypogammaglobulinemia. It is characterized by increased susceptibility to bacterial, viral, and fungal infections, as well as autoimmunity. Most patients have no circulating B cells. Methods. The French DEFicit Immunitaire de l'adulte cohort provides detailed clinical and immunological descriptions of 690 adults with primary hypogammaglobulinemia. Comparisons between patients with GS, those with common variable immunodeficiency (CVID), and those with B− CVID (circulating B cells Results. Twenty-one patients had GS and 440 had CVID, including 39 B− CVID, with a median age at diagnosis of 60, 35, and 34 years, respectively. Invasive bacterial infections were observed in 90.5% of GS, 54% of CVID, and 72% of B− CVID patients. Eight patients with GS had opportunistic infections, despite normal peripheral CD4+ T-cell numbers. Autoimmune complications were demonstrated in 76% of GS, 29% of CVID, and 26% of B− CVID patients. The spectrum of autoimmunity in GS was uncommon, consisting of oral lichen planus, graft-vs-host disease–like colitis, and pure red cell aplasia, different from the pattern observed in CVID patients. GS patients did not display lymphoid hyperplasia nor lymphoma, unlike those with CVID or B− CVID. Conclusions. GS differs notably from CVID and B− CVID: very late onset, no familial cases, and absence of lymphoid hyperplasia. The key observation is the very high frequency of invasive bacterial infections in GS, an issue that physicians should be aware of.
- 31 March 2015
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 61 (2) , e13-e19
Open AccessGood Syndrome: An Adult-Onset Immunodeficiency Remarkable for Its High Incidence of Invasive Infections and Autoimmune Complications
Background. Good syndrome (GS) is a rare condition in which thymoma is associated with hypogammaglobulinemia. It is characterized by increased susceptibility to bacterial, viral, and fungal infections, as well as autoimmunity. Most patients have no circulating B cells. Methods. The French DEFicit Immunitaire de l'adulte cohort provides detailed clinical and immunological descriptions of 690 adults with primary hypogammaglobulinemia. Comparisons between patients with GS, those with common variable immunodeficiency (CVID), and those with B− CVID (circulating B cells Results. Twenty-one patients had GS and 440 had CVID, including 39 B− CVID, with a median age at diagnosis of 60, 35, and 34 years, respectively. Invasive bacterial infections were observed in 90.5% of GS, 54% of CVID, and 72% of B− CVID patients. Eight patients with GS had opportunistic infections, despite normal peripheral CD4+ T-cell numbers. Autoimmune complications were demonstrated in 76% of GS, 29% of CVID, and 26% of B− CVID patients. The spectrum of autoimmunity in GS was uncommon, consisting of oral lichen planus, graft-vs-host disease–like colitis, and pure red cell aplasia, different from the pattern observed in CVID patients. GS patients did not display lymphoid hyperplasia nor lymphoma, unlike those with CVID or B− CVID. Conclusions. GS differs notably from CVID and B− CVID: very late onset, no familial cases, and absence of lymphoid hyperplasia. The key observation is the very high frequency of invasive bacterial infections in GS, an issue that physicians should be aware of.